These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 29526285)

  • 1. Left Atrial Appendage Occlusion: Data Update.
    Price MJ
    Interv Cardiol Clin; 2018 Apr; 7(2):159-168. PubMed ID: 29526285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indication, Patient Selection, and Referral Pathways for Left Atrial Appendage Closure.
    Dar T; Turagam MK; Yarlagadda B; Tantary M; Sheldon SH; Lakkireddy D
    Interv Cardiol Clin; 2018 Apr; 7(2):169-183. PubMed ID: 29526286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Transcatheter Left Atrial Appendage Closure for Stroke Prevention in Patients with Atrial Fibrillation.
    Price MJ
    Prog Cardiovasc Dis; 2018; 60(4-5):542-549. PubMed ID: 29339165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History of Percutaneous Left Atrial Appendage Occlusion with AMPLATZER Devices.
    Meier B; Stegink W; Tzikas A
    Interv Cardiol Clin; 2018 Apr; 7(2):151-158. PubMed ID: 29526284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, Characteristics, and Clinical Course of Device-Related Thrombus After Watchman Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients.
    Kubo S; Mizutani Y; Meemook K; Nakajima Y; Hussaini A; Kar S
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1380-1386. PubMed ID: 29759668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation.
    Pheerawong P; Songmuang SB; Lertsuwunseri V; Satitthummanid S; Srimahachota S
    J Med Assoc Thai; 2015 Oct; 98(10):942-9. PubMed ID: 26638585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left atrial appendage occlusion: rationale, evidence, devices, and patient selection.
    Piccini JP; Sievert H; Patel MR
    Eur Heart J; 2017 Mar; 38(12):869-876. PubMed ID: 27628431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: Understanding the differences in the location and type of leaks and their clinical implications.
    Pillarisetti J; Reddy YM; Gunda S; Swarup V; Lee R; Rasekh A; Horton R; Massumi A; Cheng J; Bartus K; Badhwar N; Han F; Atkins D; Bommana S; Earnest M; Nath J; Ferrell R; Bormann S; Dawn B; Di Biase L; Mansour M; Natale A; Lakkireddy D
    Heart Rhythm; 2015 Jul; 12(7):1501-7. PubMed ID: 25778430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the WATCHMAN left atrial appendage closure device.
    Alli O; Holmes D
    Expert Rev Med Devices; 2014 Nov; 11(6):541-51. PubMed ID: 25060590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit.
    Gangireddy SR; Halperin JL; Fuster V; Reddy VY
    Eur Heart J; 2012 Nov; 33(21):2700-8. PubMed ID: 23008509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous closure of the left atrial appendage for prevention of thromboembolism in atrial fibrillation for patients with contraindication to or failure of oral anticoagulation: a single-center experience.
    Faustino A; Paiva L; Providência R; Trigo J; Botelho A; Costa M; Leitão-Marques A
    Rev Port Cardiol; 2013 Jun; 32(6):461-71. PubMed ID: 23639325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL.
    Freeman JV; Hutton DW; Barnes GD; Zhu RP; Owens DK; Garber AM; Go AS; Hlatky MA; Heidenreich PA; Wang PJ; Al-Ahmad A; Turakhia MP
    Circ Arrhythm Electrophysiol; 2016 Jun; 9(6):. PubMed ID: 27307517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device.
    Enomoto Y; Gadiyaram VK; Gianni C; Horton RP; Trivedi C; Mohanty S; Di Biase L; Al-Ahmad A; Burkhardt JD; Narula A; Janczyk G; Price MJ; Afzal MR; Atoui M; Earnest M; Swarup V; Doshi SK; van der Zee S; Fisher R; Lakkireddy DR; Gibson DN; Natale A; Reddy VY
    Heart Rhythm; 2017 Jan; 14(1):19-24. PubMed ID: 27771552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of left atrial appendage occlusion in high-risk patients.
    Masoud A; Bartoletti S; Fairbairn T; Khurana A; Velavan P; Morrison WL; Khalatbari A; Aggarwal S; Sharma N; Kirchhof P; Gupta D
    Heart; 2018 Apr; 104(7):594-599. PubMed ID: 29122931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The left atrial appendage: from embryology to prevention of thromboembolism.
    Patti G; Pengo V; Marcucci R; Cirillo P; Renda G; Santilli F; Calabrò P; De Caterina AR; Cavallari I; Ricottini E; Parato VM; Zoppellaro G; Di Gioia G; Sedati P; Cicchitti V; Davì G; Golia E; Pariggiano I; Simeone P; Abbate R; Prisco D; Zimarino M; Sofi F; Andreotti F; De Caterina R;
    Eur Heart J; 2017 Mar; 38(12):877-887. PubMed ID: 27122600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation.
    Landmesser U; Holmes DR
    Eur Heart J; 2012 Mar; 33(6):698-704. PubMed ID: 22041550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual leaks following percutaneous left atrial appendage occlusion: assessment and management implications.
    Raphael CE; Friedman PA; Saw J; Pislaru SV; Munger TM; Holmes DR
    EuroIntervention; 2017 Nov; 13(10):1218-1225. PubMed ID: 28691914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial.
    Belgaid DR; Khan Z; Zaidi M; Hobbs A
    Int J Cardiol; 2016 Sep; 219():177-9. PubMed ID: 27343417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous WATCHMAN Left Atrial Appendage Closure for Japanese Patients With Nonvalvular Atrial Fibrillation at Increased Risk of Thromboembolism　- First Results From the SALUTE Trial.
    Aonuma K; Yamasaki H; Nakamura M; Ootomo T; Takayama M; Ando K; Hirao K; Morino Y; Hayashida K; Kusano K; Main ML; Saito S
    Circ J; 2018 Nov; 82(12):2946-2953. PubMed ID: 30305484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for the left atrial appendage occlusion device in managing thromboembolic risk in atrial fibrillation.
    Obeyesekere MN; Lockwood S; Mottram P; Alison JF
    Intern Med J; 2012 Mar; 42(3):e15-9. PubMed ID: 22432996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.